Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
Short excerpt below. Click through to read at the original source.
Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.